Additional Opportunities to Learn & Collaborate
Dinner Course - Meeting the Customers’ Needs. What Are the Expectations of Risk-Based Monitoring?
What’s New in 2016
A Fresh Focus on Vendor Performance and Quality
Dedicated Programming for Small and Mid-Sized Pharma/Biotech
Lessons Learned on Risk-Based Monitoring from Companies Further Ahead in Implementing RBM
Discussion of New and Emerging Tech across Pharma for Clinical Trials
In-Depth Coverage of Secondary Data Use, Data Sharing and Data Privacy
Featured Presenters
Sheryl Jacobs
Vice President, Global Study Operations, Amgen
Janis Little
Vice President, Global R&D Quality, Allergan
Anita Zubak
Executive Director, Global Clinical Trial Operations IT, Merck
Marie Rosenfeld
Director, Development Operations, Contracts & Outsourcing Vendor Management Lead, Astellas
David Nickerson
Senior Director, Portfolio & Vendor Quality, Pfizer